申请人:The General Hospital Coporation
公开号:US10472346B2
公开(公告)日:2019-11-12
Provided herein are compounds and methods for treating a disorder associated with aberrant A3 peptide levels, including Alzheimer's disease. Provided herein are compositions and methods for treating a disorder associated with aberrant Aβ peptide levels, including AD. Provided herein are compounds of Formula (A) or a pharmaceutically acceptable salt thereof, wherein, L′ is selected from the group consisting of C(O), C(R1)(R2), substituted or unsubstituted —C2-6 alkylene-, and substituted or unsubstituted —C3-6 cycloalkylene.
本文提供了用于治疗与 A3 肽水平异常相关的疾病(包括阿尔茨海默病)的化合物和方法。本文提供了用于治疗与 Aβ 肽水平异常相关的疾病(包括 AD)的组合物和方法。本文提供了式(A)化合物或其药学上可接受的盐,其中,L′选自由C(O)、C(R1)(R2)、取代或未取代的-C2-6亚烷基和取代或未取代的-C3-6环亚烷基组成的组。